Vivek Trivedi is a pharmacist by training who has several years of experience in both the industry and academia. Before he was appointed an academic, he worked at Dr Reddy’s Laboratories and Phoqus Pharmaceutical Ltd. He started his academic career in 2010 as a lecturer in formulation science at the University of Greenwich, where he stayed until 2019. He then moved to the University of Kent, where he is currently employed as a senior lecturer (associate professor) in drug delivery. His research is centered around two areas: solubility improvement of BCS II drugs and non-invasive delivery of biomolecules. His interests strongly revolve around the use of green processing methods, such as supercritical carbon dioxide, to develop suitable strategies for drug delivery. His group had been working on a platform known as a solid core drug delivery systems (SCDDS) for the oral delivery of biomolecules, which entails the immobilisation of biomolecules onto an inorganic host followed by a coating with suitable excipients to target them to the lower intestine and provide sustained release. He works closely with the food and pharma industry and has also attracted funding from the European Union, the Royal Society, and the Royal Society of Chemistry to conduct research in the areas summarised above.